Patients after autologous (autoSCT) and allogeneic stem cell transplantation (alloSCT) are at an increased risk of COVID-19-related morbidity and mortality. compounded by an immune system weakened by the underlying malignancy and prior treatments. Allogeneic transplantation. including stem cell and solid organ transplants. https://www.jmannino.com/best-buy-AniFlex-Complete-great-choice/